On August 30, 2016, the US Food and Drug Administration (FDA) published final guidance in which the agency announced it does not intend to enforce its prohibition against the inclusion of National ...
OAKLAND PARK, FL--(Marketwired - Jun 2, 2016) - BioStem Technologies, Inc. ("BioStem" or the "Company") (OTC PINK: BSEM) announced today that the FDA has accepted and issued BioStem Pharmaceuticals, ...
The change would impact every package and hundreds of systems. All product labeling that carries the National Drug Code (NDC) will need to be updated if FDA finalizes its proposed rule to expand the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results